Ghana Rejects $109m U.S. Health Aid Over Sovereignty, Data and Legal Concerns

Lives at Risk as Nsoatre Hospital Crumbles Under Political Interference – Dabehene Laments

April 7, 2026

Ghana has declined a $109 million health assistance package offered under a policy initiative introduced by former U.S. President Donald Trump, citing serious concerns over national sovereignty, data protection, regulatory authority and legal control.
The proposed support formed part of the “America First Global Health Strategy,” which seeks to shift lower-income countries away from aid dependence toward greater self-reliance in tackling diseases such as HIV/AIDS, malaria and tuberculosis.
However, according to officials familiar with the negotiations, the agreement raised red flags from the outset. The United States reportedly presented Ghana with a pre-drafted Memorandum of Understanding (MoU) in November 2025 and requested its signature within a week. Ghanaian authorities objected to both the compressed timeline and the lack of joint negotiation, but say those concerns were not accommodated.
A central point of contention was a data-sharing provision that would have required Ghana to grant the United States access to citizens’ health records for up to 25 years—well beyond the five-year duration of the aid programme. The clause also permitted broad use of the data, including potential sharing with U.S.-based pharmaceutical companies, raising ethical, legal and national security concerns among Ghanaian officials.
The MoU further proposed that medicines approved by U.S. regulators could enter the Ghanaian market without undergoing local regulatory review. Authorities viewed this as a potential erosion of the mandate of Ghana’s Food and Drugs Authority and a risk to established safety protocols.
Legal provisions within the agreement also drew scrutiny. The document stipulated that any disputes would be governed by U.S. law, a condition Ghanaian officials said could limit the country’s control over interpretation and enforcement.
Financial terms added to the concerns. While the United States pledged $109 million over five years, Ghana was expected to provide $70 million in counterpart funding. Crucially, the U.S. contribution was subject to congressional approval and funding availability, whereas Ghana’s commitment was binding.
Following internal review, the Ministry of Health escalated the matter to Cabinet. On the advice of the Attorney-General, the government opted to reject the agreement in full.
Officials maintain that the decision does not signal a rejection of international support for public health programmes, but rather reflects caution over the long-term implications of the conditions attached.
Ghana’s position comes amid emerging scrutiny of similar agreements in other countries, suggesting broader concerns about the structure and terms of the policy framework